Platinum Investment Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-840,052	Closed	-$1.85M	–	120
2024 Q4	$1.85M	Sell	840,052 -252,810	-23%	-$590K	0.11%	62
2024 Q3	$1.8M	Sell	1,092,862 -103,664	-9%	-$209K	0.08%	69
2024 Q2	$2.66M	Sell	1,196,526 -401,016	-25%	-$943K	0.11%	59
2024 Q1	$4.28M	Sell	1,597,542 -1,213,013	-43%	-$2.95M	0.17%	47
2023 Q4	$8.4M	Sell	2,810,555 -378,962	-12%	-$492K	0.34%	42
2023 Q3	$3.13M	Sell	3,189,517 -280,117	-8%	-$405K	0.12%	61
2023 Q2	$4.82M	Buy	3,469,634 +889,059	+34%	+$1.24M	0.17%	56
2023 Q1	$4.1M	Buy	2,580,575 +1,150,574	+80%	+$5.94M	0.14%	64
2022 Q4	$8.91M	Hold	1,430,001	–	–	0.34%	41
2022 Q3	$9.58M	Sell	1,430,001 -193,439	-12%	-$1.33M	0.4%	41
2022 Q2	$10.3M	Sell	1,623,440 -1,089,736	-40%	-$6.18M	0.39%	40
2022 Q1	$12.6M	Hold	2,713,176	–	–	0.39%	39
2021 Q4	$13.6M	Buy	2,713,176 +1,000,000	+58%	+$8.01M	0.38%	39
2021 Q3	$20.6M	Hold	1,713,176	–	–	0.58%	32
2021 Q2	$36.2M	Buy	1,713,176 +112,563	+7%	+$2.71M	0.84%	32
2021 Q1	$44.9M	Buy	1,600,613 +37,744	+2%	+$1.11M	1%	29
2020 Q4	$40.6M	Buy	1,562,869 +696,188	+80%	+$20.9M	0.93%	30
2020 Q3	$32.2M	Buy	866,681 +15,228	+2%	+$603K	0.8%	30
2020 Q2	$43.7M	Buy	851,453 +39,761	+5%	+$1.66M	1%	26
2020 Q1	$25.6M	Buy	811,692 +773,238	+2,011%	+$40.8M	0.65%	30
2019 Q4	$2.29M	Buy	+38,454	New	+$1.73M	0.05%	63